Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 9, 2026 20:30 UTC |
Luderer AlbertDirector · Interim Chief Executive
|
PurchaseCommon Stock | 4,000 | $1.21 | $4,844.80 |
DisclosureSEC source: 0001746822-26-000005 · ownership.xml · nonDerivative · entry 1 Luderer Albert · CIK 0001746822 · Director · Interim Chief Executive 10b5-1 filing: No plan indicated Ownership: Indirect · Traditional IRA Disclosed balance after: 8,000 Read SEC document |
| August 21, 2026 Filed Aug 21, 2026 20:30 UTC |
Luderer AlbertDirector · Interim Chief Executive
|
PurchaseCommon Stock | 4,000 | $1.22 | $4,860.00 |
DisclosureSEC source: 0001746822-26-000003 · ownership.xml · nonDerivative · entry 1 Luderer Albert · CIK 0001746822 · Director · Interim Chief Executive 10b5-1 filing: No plan indicated Ownership: Indirect · Traditional IRA Disclosed balance after: 4,000 Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:28 UTC |
Adamchak MarkPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0002036536-26-000010 · ownership.xml · derivative · entry 1 Adamchak Mark · CIK 0002036536 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2036-08-02 F1 · derivative.exercise_date: The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date. F2 · balance_after: The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:27 UTC |
Dixon Jonathan V.General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001967837-26-000010 · ownership.xml · derivative · entry 1 Dixon Jonathan V. · CIK 0001967837 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2036-08-02 F1 · derivative.exercise_date: The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date. F2 · balance_after: The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:27 UTC |
OLDAKOWSKI MARKChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001745566-26-000010 · ownership.xml · derivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2036-08-02 F1 · derivative.exercise_date: The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date. F2 · balance_after: The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 21:26 UTC |
Hastie Alex ReidChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0002147380-26-000006 · ownership.xml · derivative · entry 1 Hastie Alex Reid · CIK 0002147380 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2036-08-02 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on August 2, 2027, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from August 2, 2027, subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each such applicable vesting date. F2 · balance_after: The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 00:50 UTC |
Chaubey AlkaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 24 | $1.30 | $31.20 |
DisclosureSEC source: 0001821605-26-000006 · ownership.xml · nonDerivative · entry 1 Chaubey Alka · CIK 0001821605 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 00:52 UTC |
Dixon Jonathan V.GENERAL COUNSEL
|
Tax withholdingCommon Stock | 24 | $1.30 | $31.20 |
DisclosureSEC source: 0001967837-26-000006 · ownership.xml · nonDerivative · entry 1 Dixon Jonathan V. · CIK 0001967837 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 00:51 UTC |
OLDAKOWSKI MARKCHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 27 | $1.30 | $35.10 |
DisclosureSEC source: 0001745566-26-000006 · ownership.xml · nonDerivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 868 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 00:50 UTC |
Adamchak MarkPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 7 | $1.30 | $9.10 |
DisclosureSEC source: 0002036536-26-000006 · ownership.xml · nonDerivative · entry 1 Adamchak Mark · CIK 0002036536 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| May 14, 2026 Filed May 14, 2026 22:16 UTC |
Linney YvonneDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,149 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001810930-26-000002 · ownership.xml · derivative · entry 1 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149 Underlying: Common Stock · 9,149 shares Expires 2036-05-13 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| May 14, 2026 Filed May 14, 2026 22:16 UTC |
Rajkovic AleksandarDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,149 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001909592-26-000002 · ownership.xml · derivative · entry 1 Rajkovic Aleksandar · CIK 0001909592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149 Underlying: Common Stock · 9,149 shares Expires 2036-05-13 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| May 14, 2026 Filed May 14, 2026 22:15 UTC |
Vuori Kristiina MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,149 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001612627-26-000002 · ownership.xml · derivative · entry 1 Vuori Kristiina MD · CIK 0001612627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149 Underlying: Common Stock · 9,149 shares Expires 2036-05-13 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| May 14, 2026 Filed May 14, 2026 22:15 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,149 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001238935-26-000003 · ownership.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149 Underlying: Common Stock · 9,149 shares Expires 2036-05-13 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| May 14, 2026 Filed May 14, 2026 22:14 UTC |
BARKER DAVID LDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,149 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001189124-26-000002 · ownership.xml · derivative · entry 1 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149 Underlying: Common Stock · 9,149 shares Expires 2036-05-13 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:31 UTC |
Chaubey AlkaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 18 | $1.10 | $19.80 |
DisclosureSEC source: 0001821605-26-000004 · ownership.xml · nonDerivative · entry 1 Chaubey Alka · CIK 0001821605 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 644 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:29 UTC |
Adamchak MarkPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 3 | $1.10 | $3.30 |
DisclosureSEC source: 0002036536-26-000004 · ownership.xml · nonDerivative · entry 1 Adamchak Mark · CIK 0002036536 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 3 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:28 UTC |
Dixon Jonathan V.GENERAL COUNSEL
|
Tax withholdingCommon Stock | 6 | $1.10 | $6.60 |
DisclosureSEC source: 0001967837-26-000004 · ownership.xml · nonDerivative · entry 1 Dixon Jonathan V. · CIK 0001967837 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:26 UTC |
OLDAKOWSKI MARKCHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 20 | $1.10 | $22.00 |
DisclosureSEC source: 0001745566-26-000004 · ownership.xml · nonDerivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 895 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:25 UTC |
Holmlin R. ErikDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 51 | $1.10 | $56.10 |
DisclosureSEC source: 0001579988-26-000004 · ownership.xml · nonDerivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,657 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:19 UTC |
Adamchak MarkPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,890 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0002036536-26-000002 · ownership.xml · derivative · entry 1 Adamchak Mark · CIK 0002036536 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,890 Underlying: Common Stock · 10,890 shares Expires 2036-02-01 F1 · derivative.exercise_date: 100% of the shares subject to the option vest on the one-year anniversary of the grant date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:18 UTC |
Chaubey AlkaCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 27,737 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001821605-26-000002 · ownership.xml · derivative · entry 1 Chaubey Alka · CIK 0001821605 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,737 Underlying: Common Stock · 27,737 shares Expires 2036-02-01 F1 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:17 UTC |
OLDAKOWSKI MARKCHIEF OPERATING OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 27,737 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001745566-26-000002 · ownership.xml · derivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,737 Underlying: Common Stock · 27,737 shares Expires 2036-02-01 F1 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:16 UTC |
Dixon Jonathan V.GENERAL COUNSEL
|
GrantStock Option (Right to Buy) · Derivative | 26,117 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001967837-26-000002 · ownership.xml · derivative · entry 1 Dixon Jonathan V. · CIK 0001967837 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,117 Underlying: Common Stock · 26,117 shares Expires 2036-02-01 F1 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:14 UTC |
Holmlin R. ErikDirector · PRESIDENT AND CEO
|
GrantStock Option (Right to Buy) · Derivative | 69,484 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001579988-26-000002 · ownership.xml · derivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,484 Underlying: Common Stock · 69,484 shares Expires 2036-02-01 F1 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:49 UTC |
OLDAKOWSKI MARKChief Operating Officer
|
Tax withholdingCommon Stock | 59 | $4.06 | $239.54 |
DisclosureSEC source: 0001745566-25-000005 · wk-form4_1757710167.xml · nonDerivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915 F1 · kind: The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 21:02 UTC Amendment |
OLDAKOWSKI MARKChief Operating Officer
|
Tax withholdingCommon Stock | 59 | $4.06 | $239.54 |
DisclosureSEC source: 0001745566-25-000007 · wk-form4a_1757710939.xml · nonDerivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915 F1 · kind: The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:49 UTC |
Chaubey AlkaChief Medical Officer
|
Tax withholdingCommon Stock | 51 | $4.06 | $207.06 |
DisclosureSEC source: 0001821605-25-000006 · wk-form4_1757710145.xml · nonDerivative · entry 1 Chaubey Alka · CIK 0001821605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 662 F1 · kind: The reporting person is reporting the withholding by the Issuer an aggregate of 51 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer an aggregate of 51 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:50 UTC |
Linney YvonneDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001411690-25-000068 · wk-form4_1749761441.xml · derivative · entry 1 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 16:50 UTC |
Mamuszka HannahDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001411690-25-000065 · wk-form4_1749761408.xml · derivative · entry 1 Mamuszka Hannah · CIK 0001810929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:50 UTC |
Vuori Kristiina MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001411690-25-000069 · wk-form4_1749761452.xml · derivative · entry 1 Vuori Kristiina MD · CIK 0001612627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:51 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001411690-25-000070 · wk-form4_1749761462.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:50 UTC |
Luderer AlbertDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001411690-25-000067 · wk-form4_1749761430.xml · derivative · entry 1 Luderer Albert · CIK 0001746822 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:50 UTC |
BARKER DAVID LDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001411690-25-000066 · wk-form4_1749761417.xml · derivative · entry 1 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:50 UTC |
Rajkovic AleksandarDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001411690-25-000064 · wk-form4_1749761396.xml · derivative · entry 1 Rajkovic Aleksandar · CIK 0001909592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 22:59 UTC |
OLDAKOWSKI MARKChief Operating Officer
|
Tax withholdingCommon Stock | 27 | $3.69 | $99.63 |
DisclosureSEC source: 0001411690-25-000056 · wk-form4_1748991535.xml · nonDerivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 974 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 22:58 UTC |
Adamchak MarkPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 7 | $3.69 | $25.83 |
DisclosureSEC source: 0001411690-25-000055 · wk-form4_1748991525.xml · nonDerivative · entry 1 Adamchak Mark · CIK 0002036536 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 22:58 UTC |
Holmlin R. ErikDirector · President and CEO
|
Tax withholdingCommon Stock | 75 | $3.69 | $276.75 |
DisclosureSEC source: 0001411690-25-000053 · wk-form4_1748991505.xml · nonDerivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,708 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 22:58 UTC |
Chaubey AlkaChief Medical Officer
|
Tax withholdingCommon Stock | 24 | $3.69 | $88.56 |
DisclosureSEC source: 0001411690-25-000054 · wk-form4_1748991515.xml · nonDerivative · entry 1 Chaubey Alka · CIK 0001821605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 713 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 22:58 UTC |
Dixon Jonathan V.General Counsel
|
Tax withholdingCommon Stock | 25 | $3.69 | $92.25 |
DisclosureSEC source: 0001411690-25-000052 · wk-form4_1748991495.xml · nonDerivative · entry 1 Dixon Jonathan V. · CIK 0001967837 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 25 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 25 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:45 UTC |
Adamchak MarkPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 3,029 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001411690-25-000029 · wk-form4_1742337939.xml · derivative · entry 1 Adamchak Mark · CIK 0002036536 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,029 Underlying: Common Stock · 3,029 shares Expires 2035-03-13 F1 · derivative.exercise_date: 100% of the shares subject to the option vest on the one-year anniversary of the grant date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:45 UTC |
Dixon Jonathan V.General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 6,559 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001411690-25-000030 · wk-form4_1742337949.xml · derivative · entry 1 Dixon Jonathan V. · CIK 0001967837 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,559 Underlying: Common Stock · 6,559 shares Expires 0035-03-13 F1 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:45 UTC |
Holmlin R. ErikDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 17,449 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001411690-25-000028 · wk-form4_1742337929.xml · derivative · entry 3 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,449 Underlying: Common Stock · 17,449 shares Expires 2035-03-13 F2 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:45 UTC |
Holmlin R. ErikDirector · President and CEO
|
Tax withholdingCommon Stock | 198 | $3.47 | $687.06 |
DisclosureSEC source: 0001411690-25-000028 · wk-form4_1742337929.xml · nonDerivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:45 UTC |
OLDAKOWSKI MARKChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 6,966 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001411690-25-000027 · wk-form4_1742337920.xml · derivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,966 Underlying: Common Stock · 6,966 shares Expires 2035-03-13 F1 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:45 UTC |
Chaubey AlkaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 6,966 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001411690-25-000026 · wk-form4_1742337909.xml · derivative · entry 1 Chaubey Alka · CIK 0001821605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,966 Underlying: Common Stock · 6,966 shares Expires 2035-03-13 F1 · derivative.exercise_date: Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 23:57 UTC |
OLDAKOWSKI MARKChief Operating Officer
|
Tax withholdingCommon Stock | 20 | $5.73 | $114.60 |
DisclosureSEC source: 0001411690-25-000019 · wk-form4_1740009430.xml · nonDerivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,001 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F2 · balance_after: On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 60,262 less shares of common stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 23:56 UTC |
Chaubey AlkaChief Medical Officer
|
Tax withholdingCommon Stock | 18 | $5.73 | $103.14 |
DisclosureSEC source: 0001411690-25-000016 · wk-form4_1740009400.xml · nonDerivative · entry 1 Chaubey Alka · CIK 0001821605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 737 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F2 · balance_after: On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 44,568 less shares of common stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 23:57 UTC |
Dixon Jonathan V.General Counsel
|
Tax withholdingCommon Stock | 6 | $5.73 | $34.38 |
DisclosureSEC source: 0001411690-25-000018 · wk-form4_1740009420.xml · nonDerivative · entry 1 Dixon Jonathan V. · CIK 0001967837 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F2 · balance_after: On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 17,725 less shares of common stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 23:56 UTC |
Holmlin R. ErikDirector · President and CEO
|
Tax withholdingCommon Stock | 51 | $5.73 | $292.23 |
DisclosureSEC source: 0001411690-25-000017 · wk-form4_1740009410.xml · nonDerivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,981 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F1 · shares: The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F2 · balance_after: On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 120,428 less shares of common stock (119,934 less shares held directly and 494 less shares held indirectly). F3 · balance_after: Includes 2 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024 (As adjusted for the January 2025 Reverse Stock Split). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.